We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 226 results
  1. The role of the BTLA–HVEM complex in the pathogenesis of breast cancer

    Breast cancer (BC) is widely recognized as a prevalent contributor to cancer mortality and ranks as the second most prevalent form of cancer among...

    Xue Hu in Breast Cancer
    Article 14 March 2024
  2. Expression of LIGHT/TNFSF14 and Its Receptors, HVEM and LTβR, Correlates with the Severity of Fibrosis in Lacrimal Sacs from Patients with Lacrimal Duct Obstruction

    Introduction

    Fibrosis is one of the factors contributing to the development of primary acquired lacrimal duct obstruction (LDO). LIGHT (homologous to...

    Pawel Bielecki, Ewa Gindzienska-Sieskiewicz, ... Andrzej Sieskiewicz in Ophthalmology and Therapy
    Article Open access 13 November 2020
  3. HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions

    Background

    Our previous studies showed the expression of herpes virus entry mediator (HVEM) is high in ovarian cancer samples and correlated to the...

    Liyan Duan, Jie Tao, ... Jianlong Zhu in Journal of Ovarian Research
    Article Open access 20 April 2020
  4. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Patients with chronic lymphocytic leukemia (CLL) progressively develop marked immunosuppression, dampening innate and adaptive-driven antitumor...

    Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, ... Segundo Gonzalez in Cancer Immunology, Immunotherapy
    Article Open access 11 April 2023
  5. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines

    Purpose

    Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor, with an overall poor prognosis after diagnosis. Conventional...

    Julia Schatz, Alexandra Ladinig, ... Anja Derer in Strahlentherapie und Onkologie
    Article Open access 08 December 2022
  6. Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study

    Background

    Recent researches suggest that the CD160/HVEM/LIGHT/BTLA signaling pathway may contribute to the pathogeneses of autoimmune diseases, but...

    Weiwei He, **g Zhao, ... **-an Zhang in BMC Endocrine Disorders
    Article Open access 08 July 2021
  7. The kinetics of inhibitory immune checkpoints during and post-COVID-19: the knowns and unknowns

    The immune system is tightly regulated to prevent immune reactions to self-antigens and to avoid excessive immune responses during and after...

    Ensiye Torki, Arezou Gharezade, ... Hamed Fouladseresht in Clinical and Experimental Medicine
    Article 11 September 2023
  8. Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia

    Increasing understanding of the complex interaction between leukemic and immune cells, which is responsible for tumor progression and immune evasion,...

    Saeid Taghiloo, Hossein Asgarian-Omran in Current Treatment Options in Oncology
    Article 10 August 2023
  9. Effects of immune cells in mediating the relationship between gut microbiota and myelodysplastic syndrome: a bidirectional two-sample, two-step Mendelian randomization study

    Background

    The definitive establishment of a causal relationship between gut microbiota and myelodysplastic syndrome (MDS) has not been achieved....

    Zuxi Feng, Min**g Liao, ... Liansheng Zhang in Discover Oncology
    Article Open access 31 May 2024
  10. A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma

    Background

    HCC is an extremely malignant tumor with a very poor prognosis. In 2023, a brand-new kind of cell death known as disulfidptosis was...

    Yuxin Chen, Wanying Xue, ... Yuanyuan Wang in Journal of Cancer Research and Clinical Oncology
    Article Open access 18 July 2023
  11. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis

    Background

    Herpesvirus entry mediator (HVEM) has been suggested to play various roles in cancer biology. The authors report that HVEM expression in...

    Yoshiyuki Sasaki, Daisuke Hokuto, ... Masayuki Sho in Annals of Surgical Oncology
    Article 16 July 2019
  12. Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure

    Immune checkpoint molecules are physiological regulators of the adaptive immune response. Immune checkpoint inhibitors (ICIs), such as monoclonal...

    Tamás G. Gergely, Zsófia D. Drobni, ... Zoltán V. Varga in Nature Reviews Cardiology
    Article 26 January 2024
  13. The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma

    Melanoma is responsible for 90% of skin cancer-related deaths. Major therapeutic advances have led to a considerable improvement in the prognosis of...

    Marie-Léa Gauci, Jérôme Giustiniani, ... Anne Marie-Cardine in Cancer Immunology, Immunotherapy
    Article Open access 15 April 2022
  14. Investigating the causal relationship between immune cell and Alzheimer’s disease: a mendelian randomization analysis

    Background

    Complex interactions between the immune system and the brain may affect neural development, survival, and function, with etiological and...

    Min Shen, Linlin Zhang, ... Yuxia Ma in BMC Neurology
    Article Open access 18 March 2024
  15. Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment

    Background

    Immune checkpoints are crucial for the maintenance of subtle balance between self-tolerance and effector immune responses, but the role of...

    Huaxin Chen, **gyu Zhou, ... Qinfang Ou in BMC Infectious Diseases
    Article Open access 14 June 2022
  16. Identification of allograft inflammatory factor-1 suppressing the progression and indicating good prognosis of osteosarcoma

    Background

    Osteosarcoma is one of the most common cancers worldwide. Intense efforts have been made to elucidate the pathogeny, but the mechanisms of...

    Wenda Liu, Tao Shi, ... **gteng Chen in BMC Musculoskeletal Disorders
    Article Open access 23 March 2024
  17. A case report of long-delayed diagnosis of pseudorabies virus encephalitis with endophthalmitis: lessons from metagenomic next generation sequencing

    Background

    Pseudorabies virus (PRV) was thought to only infect animals. Recent studies have shown that it can also infect human.

    Case presentation ...
    Yi Zhang, Lei Fang, ... Ling Li in BMC Neurology
    Article Open access 16 May 2023
  18. Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) responds poorly to systemic treatment, including new immunotherapeutic approaches. Biomarkers are urgently...

    David Digomann, Max Heiduk, ... Adrian M. Seifert in npj Precision Oncology
    Article Open access 14 October 2023
  19. A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG

    Background

    Globally, gastric cancer (GC) is a common and lethal solid malignant tumor. Identifying the molecular signature and its functions can...

    Hui Shi, Jiangling Duan, ... Ming Lu in Clinical and Translational Oncology
    Article 14 November 2022
Did you find what you were looking for? Share feedback.